Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Cancer Non-resectable × pamrevlumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3 Pancreatic Cancer Non-resectable 1 Neoplasms 1

Interventions

Gemcitabine 3 Leucovorin 2 Fluorouracil 2 tremelimumab 1 pamrevlumab 1 irinotecan sucrosofate 1 folfirinox 1 durvalumab 1 Taxes 1 Radiosurgery 1 Oxaliplatin 1 Medical Marijuana 1 Irinotecan 1 Heavy Ion Radiotherapy 1 Chemoradiotherapy 1 Capecitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03941093 2024-11-05

LAPIS

Kyntra Bio

Phase 3 Completed

284 enrolled 14 charts

Gastrointestinal

Pancreatic Cancer Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡